Xenogenics Corporation (“Xenogenics”), a development-stage medical device company, is focused on the design of next-generation bioabsorbable stents for interventional cardiology and peripheral vascular applications. Xenogenics is a majority owned subsidiary of MultiCell Technologies, Inc. (OTCBB: MCET).
